Treatment research progress on the treatment of neurofibromatosis type 2-associated vestibular schwannoma.
- Author:
Yingchao ZHAO
;
Qin YANG
;
Yao JIANG
- Publication Type:Journal Article
- MeSH:
Humans;
Molecular Targeted Therapy;
Neurofibromatosis 2;
radiotherapy;
surgery;
therapy;
Neuroma, Acoustic;
radiotherapy;
surgery;
therapy
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2015;29(10):955-958
- CountryChina
- Language:Chinese
-
Abstract:
Neurofibromatosis type 2 (NF2) is a dominantly inherited genetic condition. Bilateral vestibular schwannoma, which are benign tumors, composed of neoplastic Schwann cells that arise from the eighth cranial nerve, are the hallmark of NF2. Standard approaches for treatment of growing vestibular schwannoma include observation, surgical removal and radiation therapy. Molecular targeted therapies also present great prosperity in recent years. In this review, we summarize the latest progresses on the treatment of NF2-associated vestibular schwannoma.
